Accordingly, future studies are warranted to further investigate the detailed molecular mechanisms of the combined treatment with BBR and OPCs on MYB and PI3K-Akt signaling pathway, including the validation of our findings in the tumor spheroids and animal models. The gene discussed is AKT1; the disease is neoplasm.